EpiPens still costly despite generic alternatives, other reforms
If Meg White ever got stung by a bee, her EpiPen could ultimately save her life.
Feb 12, 2020
0
7
If Meg White ever got stung by a bee, her EpiPen could ultimately save her life.
Feb 12, 2020
0
7
China reported a rise in new virus cases Monday, possibly denting optimism that disease control measures including isolating major cities might be working, while the operator of a cruise ship in Japan reported dozens of new ...
Feb 10, 2020
0
2
The manager of the Wushang Mart in Wuhan, the locked-down city at the heart of China's virus outbreak, says its shelves are loaded with 50% more vegetables and other food than usual to reassure jittery customers.
Feb 8, 2020
0
4
(HealthDay)—Reference prices are associated with lower prices paid by employers and lower cost sharing by employees, according to a study published online Feb. 5 in JAMA Network Open.
Feb 6, 2020
0
1
(HealthDay)—If you don't need insulin, you probably haven't paid much attention to its skyrocketing cost, but new research shows that exorbitant drug pricing eventually affects everyone.
Feb 4, 2020
0
2
Comparison shopping for airfare, a TV or a car can be straightforward online. The same cannot be said for checking what hospitals charge for a standard radiation treatment for prostate cancer, according to a report published ...
Jan 16, 2020
0
2
U.S. drug companies have started the new year by raising the prices of hundreds of medications.
Jan 7, 2020
0
2
Most people who experience severe trauma recover their health. But 23 percent develop PTSD, a difficult-to-treat illness that combines intrusive thoughts about the trauma, avoidance of reminders of it, low mood and an exaggerated ...
Dec 12, 2019
0
34
Since the introduction of an alcohol floor price in the Northern Territory, presentations for acute alcohol misuse at Alice Springs Hospital's intensive care unit have dropped by 54 percent, according to the authors of a ...
Dec 9, 2019
0
1
Prices for prescription drugs edged down by 1% last year, a rare result driven by declines for generics and slow, low growth in the cost of brand-name medications, the government said Thursday.
Dec 5, 2019
0
13